Amjevita
Payments companies reported to CMS as associated with Amjevita. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Amjevita, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Amjevita
These are the largest totals companies reported as associated with Amjevita. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Nehal Mehta | Philadelphia, PA | Cardiovascular Disease | $10,808.21 |
| Paul Yamauchi | Santa Monica, CA | Dermatology | $2,724.40 |
| Gil Melmed | Los Angeles, CA | Gastroenterology (Internal Medicine) | $2,644.51 |
| John Tesser | Phoenix, AZ | Rheumatology | $1,000.00 |
| Ronald Reichman | Culver City, CA | Rheumatology | $440.12 |
| Antonio Giannelli | Lansing, MI | Physician Assistant | $427.65 |
| Albert Katz | Tarzana, CA | Rheumatology | $357.01 |
| Kostas Botsoglou | Cheektowaga, NY | Rheumatology | $354.97 |
| Joshua June | Lansing, MI | Rheumatology | $350.81 |
| Katherine Mamo | East Lansing, MI | Nurse Practitioner | $340.40 |
Prescribed Amjevita?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.